Vacquinol-1|NSC 13316|DC Chemicals

Cas No.:	5428-80-8
Chemical Name:	Vacquinol-1
Synonyms:	4-Quinolinemethanol,2-(4-chlorophenyl)-a-2-piperidinyl-;[2-(4-chlorophenyl)quinolin-4-yl]-(2-piperidyl)methanol;[2-(4-chlorophenyl)quinolin-4-yl]-piperidin-2-ylmethanol;Vacquinol-1;(2-(4-chlorophenyl)-4-quinolinyl)(2-piperidinyl)methanol;(2-(4-chlorophenyl)quinolin-4-yl)(piperidin-2-yl)methanol;[2-(4-chloro-phenyl)-[4]quinolyl]-[2]piperidyl-methanol;[2-(4-chlorophenyl)quinolin-4-yl](piperidin-2-yl)methanol;[2-(4-Chlor-phenyl)-[4]chinolyl]-[2]piperidyl-methanol;AC1L5DG6;AC1Q3NLM;NSC13316;SureCN8738855
SMILES:	C1=CC=C2C(=C1)C(=CC(=N2)C3=CC=C(C=C3)Cl)C(C4CCCCN4)O
Formula:	C₂₁H₂₁N₂OCl
M.Wt:	352.85724
Purity:	>98%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

Vacquinol-1 is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells.

Cat. No.	Product name	Field of application
DC7488	RO4987655	RO4987655(CH-4987655) is an orally active small molecule, targeting mitogen-activated protein kinase kinase 1 (MAP2K1/MEK1 IC50=5.2 nM), with potential antineoplastic activity.
DC8473	Vacquinol-1	Vacquinol-1 is an activator of MKK4-dependent macropinocytotic cell death in glioblastoma cells.
DC7243	U0126	U0126-EtOH(U-0126) is a highly selective inhibitor of MEK1/2 with IC50 of 0.07 μM/0.06 μM, 100-fold higher affinity for ΔN3-S218E/S222D MEK than PD098059.
DC1099	Trametinib	Trametinib is a highly specific and potent MEK1 and MEK2 inhibitor with IC50 of 0.92 nM and 1.8 nM, respectively.
DC7308	TAK-733	TAK-733 is a potent and selective MEK allosteric site inhibitor for MEK1 with IC50 of 3.2 nM, inactive to Abl1, AKT3, c-RAF, CamK1, CDK2, c-Met, etc.
DC7808	Refametinib (BAY86-9766)	Refametinib (RDEA119, Bay 86-9766) is a potent, ATP non-competitive and highly selective inhibitor of MEK1 and MEK2 with IC50 of 19 nM and 47 nM, respectively.
DC1056	PD0325901 (Mirdametinib)	PD0325901 (PD325901) is selective and non ATP-competitive MEK inhibitor with IC50 of 0.33 nM.
DC5100	PD 98059	PD 98059 is a selective inhibitor of MEK and blocker of MAPK
DC7723	OTS964， OTS 964	OTS964 is a novel TOPK(T–lymphokine-activated killer cell–originated protein kinase) inhibitor.
DC4177	Cobimetinib(GDC-0973; XL518)	GDC-0973 is a potent, highly selective inhibitor of mitogen-activated protein kinase kinase, also known as MEK, a serine/threonine kinase that is a component of the RAS/RAF/MEK/ERK pathway.